Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes

Successful Weight Loss Among Obese U.S. Adults

(2012) Jacinda M. Nicklas et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

American Association of Clinical Endocrinologists' Position Statement on Obesity and Obesity Medicine

(2012) Jeffrey Mechanick et al.   Endocrine Practice

Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

(2012) Patrick M. O'Neil et al.   Obesity

Anti-Obesity Drugs: A Review about Their Effects and Safety

(2012) Jun Goo Kang et al.   Diabetes & Metabolism Journal

Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage

(2011) A Anandacoomarasamy et al.   ANNALS OF THE RHEUMATIC DISEASES

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

(2011) I. D. Caterson et al.   DIABETES OBESITY & METABOLISM

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study

(2010) T Handjieva-Darlenska et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET